Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.985 USD | +3.29% | -12.06% | -6.85% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.85% | 493M | |
-2.71% | 103B | |
+1.73% | 95.28B | |
+1.46% | 22.15B | |
-15.71% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.98% | 16.05B | |
+4.71% | 13.68B | |
+35.48% | 12.17B |
- Stock Market
- Equities
- ALLO Stock
- News Allogene Therapeutics, Inc.
- Goldman Sachs Adjusts Allogene Therapeutics' Price Target to $9 from $12, Keeps Neutral Rating